Elevated Hs-CRP Levels Are Associated with Higher Risk of Intracranial Arterial Stenosis

Bing-Jie Su1, Yi Dong2, Chen-Chen Tan1

  • 1Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, 266071, China.

Neurotoxicity Research
|November 7, 2019
PubMed

Insights

Elevated high-sensitivity C-reactive protein (hs-CRP) levels are linked to a higher risk of intracranial arterial stenosis (ICAS). This association was observed in both stroke patients and individuals without a stroke history.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Biomarkers

Background:

  • The relationship between high-sensitivity C-reactive protein (hs-CRP) and intracranial arterial stenosis (ICAS) requires further clarification.
  • Inflammation plays a role in atherosclerosis and cerebrovascular diseases.

Purpose of the Study:

  • To investigate the association between serum hs-CRP levels and the presence of ICAS.
  • To determine if hs-CRP is a risk factor for ICAS in a population aged 40 years and older.

Main Methods:

  • A cohort of 1458 participants aged ≥40 years underwent magnetic resonance angiography (MRA) to assess for ICAS.
  • Participants were categorized based on stroke status and ICAS presence.
  • Multivariable logistic regression models were employed to analyze the relationship between hs-CRP levels and ICAS.

Main Results:

  • Intracranial arterial stenosis (ICAS) was identified in 432 (29.63%) participants.
  • Patients in the stroke group exhibited significantly higher hs-CRP levels compared to the non-stroke group (p < 0.001).
  • Higher hs-CRP levels were significantly associated with the presence of ICAS (p < 0.001). The highest quartile of hs-CRP showed the strongest association with ICAS in both stroke and non-stroke groups (OR 2.512 and 2.534, respectively).

Conclusions:

  • Elevated serum hs-CRP levels are independently associated with an increased risk of intracranial arterial stenosis (ICAS).
  • hs-CRP may serve as a valuable biomarker for identifying individuals at risk for ICAS, irrespective of stroke history.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
498
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
346
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
829
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
675
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
352
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
421